DENVER, CO
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER, founded in 2003, is a mid-sized nonprofit in the Community Improvement sector that reported $28.6M in total revenue in fiscal year 2024. Revenue grew 16% year-over-year, indicating healthy expansion. Expenses of $26.0M left a modest 9% surplus.
BE THE MULTIDISCIPLINARY WORLD AUTHORITY ON LUNG AND OTHER THORACIC CANCERS THROUGH COLLLABORATIVE SCIENCE, EDUCATION, AND ADVOCACY IN ORDER TO ENSURE OPTIMAL PREVENTION AND PATIENT CARE.
MEMBERSHIPS AND OTHER PROGRAMS TO ADVANCE THE STUDY OF LUNG CANCER.
PUBLICATIONS & SCIENTIFIC PROGRAMS TO PROVIDE EDUCATION TO THE WORLDWIDE LUNG CANCER COMMUNITY REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT.
MEETINGS & WEB SEMINARS TO DISSEMINATE INFORMATION REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $28,627,995 | $24,616,047 | +0.2% |
| Expenses | $26,021,479 | $20,136,070 | +0.3% |
| Net Income | $2,606,516 | $4,479,977 | -0.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KAREN L KELLY MD | CEO | 40.00 |
Officer
|
$465,025 | $47,084 | $512,109 |
| JOHN SKADOW | CFO | 40.00 |
Officer
|
$206,433 | $47,773 | $254,206 |
| MATTHEW YEINGST | VP | 40.00 |
Key Emp
|
$212,670 | $41,536 | $254,206 |
| MICHAEL HOEHN | VP | 40.00 |
Key Emp
|
$229,101 | $23,451 | $252,552 |
| MURRY WYNES | SENIOR ADVIS | 40.00 |
Highest
|
$191,362 | $21,172 | $212,534 |
| JENNIFER KING | VP | 32.00 |
Key Emp
|
$191,976 | $14,933 | $206,909 |
| BECKY BUNN | DIRECTOR | 40.00 |
Highest
|
$147,378 | $35,333 | $182,711 |
| KATHLEEN DOHERTY | DIRECTOR | 40.00 |
Highest
|
$135,620 | $26,578 | $162,198 |
| SUNHEE MALINOWSKI | CONTROLLER | 40.00 |
Highest
|
$131,820 | $15,224 | $147,044 |
| KELSEY WOOD | DIRECTOR | 40.00 |
Highest
|
$131,136 | $14,499 | $145,635 |
| ELIZABETH DONAHUE | CFO | 40.00 |
Officer
|
$9,745 | $1,042 | $10,787 |
| HEATHER WAKELEE MD FASCO | PAST PRESIDE | 3.00 |
Director
|
$0 | $0 | $0 |
| JOE CHANG MD PHD FASTRO | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| MING-SOUND TSAO MD FRCPC | SECRETARY | 3.00 |
Director
|
$0 | $0 | $0 |
| NATASHA LEIGHL MD MMSC FRCPC | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| IGNACIO WISTUBA MD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| JHANELLE GRAY MD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| PAULA UGALDE MD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| LECIA VANDAM SEQUIST MD MPH | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| ANTONI ROSELL MD PHD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| BENJAMIN SOLOMON MBBS PHD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| CAICUN ZHOU MD PHD | PRESIDENT EL | 3.00 |
Director
|
$0 | $0 | $0 |
| CARLOS GIL FERREIRA MD PHD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| JOACHIM AERTS MD PHD | TREASURER | 3.00 |
Director
|
$0 | $0 | $0 |
| MORTEN QUIST PHD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| PAUL VAN SCHIL MD PHD | PRESIDENT | 3.00 |
Director
|
$0 | $0 | $0 |
| WEN-ZHAO ZHONG MD PHD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| YOUNG TAE KIM MD PHD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $28,627,995 | $26,021,479 | $35,555,926 | $2,606,516 |
| 2023 | $24,616,047 | $20,136,070 | $31,025,690 | $4,479,977 |
| 2022 | $11,551,380 | $14,627,829 | $25,381,895 | $-3,076,449 |
| 2021 | $13,685,313 | $11,754,042 | $23,299,078 | $1,931,271 |
| 2020 | $6,883,020 | $10,088,011 | $21,887,506 | $-3,204,991 |
| 2019 | $18,805,451 | $17,830,693 | $21,412,257 | $974,758 |
| 2018 | $14,022,444 | $14,492,345 | $18,593,846 | $-469,901 |
Compare INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER with other nonprofits in Colorado and across the country.